Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia ; volume:23 ; number:1 ; day:31 ; month:5 ; year:2023 ; pages:1-15 ; date:12.2023
BMC cancer ; 23, Heft 1 (31.5.2023), 1-15, 12.2023
- Urheber
-
Shin, Jiwon
Kim, Min-Jung
Quan, Xingguo
Kim, Ji Woong
Lee, Sukmook
Park, SaeGwang
Jeong, Jee-Yeong
Yea, Kyungmoo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-10975-3
- URN
-
urn:nbn:de:101:1-2023091208470312037054
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shin, Jiwon
- Kim, Min-Jung
- Quan, Xingguo
- Kim, Ji Woong
- Lee, Sukmook
- Park, SaeGwang
- Jeong, Jee-Yeong
- Yea, Kyungmoo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Chemotherapy-induced thrombocytopenia: literature review
Risk Factors of Chemotherapy-Induced Thrombocytopenia After Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancies
Elevated BNP caused by recombinant human interleukin-11 treatment in patients with chemotherapy-induced thrombocytopenia
The three pillars in treating antibody-mediated encephalitis
Dimethyl fumarate inhibits antibody-induced platelet destruction in immune thrombocytopenia mouse
Efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a meta-analysis
Challenges in treating primary immune thrombocytopenia patients undergoing COVID-19 vaccination: A retrospective study
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone
Efficacy of human interleukin-11 analogs for treating dengue fever-associated thrombocytopenia: a prospective cohort
The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern China
HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia
Immune thrombocytopenia (ITP)
Chemotherapy-induced thrombocytopenia: literature review
Risk Factors of Chemotherapy-Induced Thrombocytopenia After Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancies
Elevated BNP caused by recombinant human interleukin-11 treatment in patients with chemotherapy-induced thrombocytopenia
The three pillars in treating antibody-mediated encephalitis
Dimethyl fumarate inhibits antibody-induced platelet destruction in immune thrombocytopenia mouse
Efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a meta-analysis
Challenges in treating primary immune thrombocytopenia patients undergoing COVID-19 vaccination: A retrospective study
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone
Efficacy of human interleukin-11 analogs for treating dengue fever-associated thrombocytopenia: a prospective cohort
The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern China
HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia
Immune thrombocytopenia (ITP)
Chemotherapy-induced thrombocytopenia: literature review
Risk Factors of Chemotherapy-Induced Thrombocytopenia After Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancies
Elevated BNP caused by recombinant human interleukin-11 treatment in patients with chemotherapy-induced thrombocytopenia
The three pillars in treating antibody-mediated encephalitis
Dimethyl fumarate inhibits antibody-induced platelet destruction in immune thrombocytopenia mouse
Efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a meta-analysis
Challenges in treating primary immune thrombocytopenia patients undergoing COVID-19 vaccination: A retrospective study
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone
Efficacy of human interleukin-11 analogs for treating dengue fever-associated thrombocytopenia: a prospective cohort
The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern China
HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia